|
Re: RESVERLOGIX ANNOUNCES PROPOSED OFFERING OF UNITS April 17, 2018
|
1
|
Resverlogix Corp.
|
May 14, 2019 09:05PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 11:15AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 09:32AM
|
|
Re: Resverlogix Announces Ninth Positive DSMB Recommendation for Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 12:32PM
|
|
Re: Resverlogix Announces Change to its Board of Directors
|
6
|
Resverlogix Corp.
|
Dec 11, 2019 09:39AM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
1
|
Resverlogix Corp.
|
Sep 23, 2019 08:39AM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
2
|
Resverlogix Corp.
|
Sep 23, 2019 08:48AM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
1
|
Resverlogix Corp.
|
Sep 23, 2019 08:50AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
9
|
Resverlogix Corp.
|
Dec 22, 2020 08:06AM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
1
|
Resverlogix Corp.
|
Aug 22, 2019 09:00PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 06:14PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
4
|
Resverlogix Corp.
|
Dec 05, 2019 08:48PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
3
|
Resverlogix Corp.
|
Dec 05, 2019 08:58PM
|
|
Re: Recent rise in SP...
|
2
|
Resverlogix Corp.
|
Sep 28, 2020 12:16PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 09:52AM
|
|
Re: Reading between the lines in Management's comments
|
3
|
Resverlogix Corp.
|
Apr 18, 2019 10:46AM
|
|
Re: Re-visiting Tundup's all-time top-rated message
|
2
|
Resverlogix Corp.
|
Jan 22, 2019 11:49AM
|
|
Re: Questions on the last couple days of trading
|
|
Resverlogix Corp.
|
Mar 15, 2019 10:26AM
|
|
Re: Questions about units
|
1
|
Resverlogix Corp.
|
May 17, 2019 09:12AM
|
|
Re: Question...glimmers of hope?
|
5
|
Resverlogix Corp.
|
Sep 30, 2019 03:11PM
|
